| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/22/1996 | WO1996005297A1 Method of gene therapy using dna vectors without selection marker gene |
| 02/22/1996 | WO1996005295A2 An improved cleaning composition |
| 02/22/1996 | WO1996005293A1 Molecular presenting system |
| 02/22/1996 | WO1996005292A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | WO1996005288A2 T cell activation |
| 02/22/1996 | WO1996005232A1 Apoptosis related protein bcl-y, and methods of use thereof |
| 02/22/1996 | WO1996005230A1 MONOCLONAL ANTIBODY AGAINST HUMAN Mx PROTEIN MxA |
| 02/22/1996 | WO1996005229A1 Human-murine chimeric antibodies against respiratory syncytial virus |
| 02/22/1996 | WO1996005227A1 Peptides inhibiting the cholesterol ester transfer protein and therapeutic uses thereof |
| 02/22/1996 | WO1996005226A1 POLYNUCLEOTIDE ENCODING C5a RECEPTOR |
| 02/22/1996 | WO1996005225A1 Adrenergic receptor |
| 02/22/1996 | WO1996005224A1 Single-chain forms of the glycoprotein hormone quartet |
| 02/22/1996 | WO1996005223A1 Abundant extracellular products and methods for their production and use |
| 02/22/1996 | WO1996005222A1 Purification and pharmaceutical compositions containing type g botulinum neurotoxin |
| 02/22/1996 | WO1996005221A1 Calcitonin receptor |
| 02/22/1996 | WO1996005219A1 Purified form of streptogramines, preparation thereof and pharmaceutical compositions containing it |
| 02/22/1996 | WO1996005218A1 Delivery of nucleic acids |
| 02/22/1996 | WO1996005214A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | WO1996004929A1 Antibacterial composition containing multimeric alpha-lactalbumin |
| 02/22/1996 | WO1996004928A1 Calcitonin gene related peptide receptor |
| 02/22/1996 | WO1996004927A1 NOVEL GnRH ANALOGUES WITH ANTITUMOUR EFFECTS AND PHARMACEUTICAL COMPOSITIONS THEREOF |
| 02/22/1996 | WO1996004926A1 TWO NON-CONTIGUOUS REGIONS CONTRIBUTE TO NIDOGEN BINDING TO A SINGLE EGF-LIKE MOTIF OF THE LAMININ η1 CHAIN |
| 02/22/1996 | WO1996004916A1 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions |
| 02/22/1996 | WO1996004790A1 Dna encoding a human betaine/gaba transporter and uses thereof |
| 02/22/1996 | DE4425645A1 New lysostaphin gene with deletion in pro-segment repeat region |
| 02/22/1996 | DE19503359C1 Plants with increased tolerance towards stress |
| 02/22/1996 | CA2197801A1 T cell activation |
| 02/22/1996 | CA2197712A1 Vaccines containing borrelia burgdorferi ospg |
| 02/22/1996 | CA2197569A1 Nucleotide and amino acid sequences of the envelope 1 and core genes of hepatitis c virus |
| 02/22/1996 | CA2197497A1 Novel vesicular acetylcholine carrier |
| 02/22/1996 | CA2197446A1 Antigenically-marked non-infectious retrovirus-like particles |
| 02/22/1996 | CA2197420A1 Construction of nucleoprotein based assemblies comprising addressable components for nanoscale assembly and nanoprocessors |
| 02/22/1996 | CA2197203A1 An improved cleaning composition |
| 02/22/1996 | CA2196788A1 Dna encoding turkey hypothalamic vasoactive intestinal peptide |
| 02/22/1996 | CA2196080A1 Protein toxins active against lepidopteran pests |
| 02/22/1996 | CA2196053A1 Two non-contiguous regions contribute to nidogen binding to a single egf-like motif of the laminin .gamma.1 chain |
| 02/22/1996 | CA2195768A1 G protein coupled receptor protein, production, and use thereof |
| 02/22/1996 | CA2173727A1 Novel gnrh analogues with antitumour effects and pharmaceutical compositions thereof |
| 02/21/1996 | EP0697218A2 Method of preparing cross-linked biomaterial compositions for use in tissue augmentation |
| 02/21/1996 | EP0697170A1 Coated pesticidal agents, processes for their preparation and compositions containing them |
| 02/21/1996 | EP0697111A1 Cell test for alzheimer's disease |
| 02/21/1996 | EP0697024A1 Downregulation of allergen-specific immune response |
| 02/21/1996 | EP0697021A1 Photo-activatable biotin derivatives and their use in suppressing interference in immuno assaying |
| 02/21/1996 | EP0696919A1 Diagnosis and treatment of erectile dysfunction |
| 02/21/1996 | EP0516785B1 RECOMBINANT ANTIBODIES SPECIFIC FOR TNF alpha |
| 02/21/1996 | CN1117051A Anti-cancer active matter Huogu mushroom essence and its extracting process |
| 02/20/1996 | US5493008 Two non-contiguous regions contribute to nidogen binding to a single EGF-like motif of the laminin γ1 chain |
| 02/20/1996 | US5493007 Oligopeptide |
| 02/20/1996 | US5493006 Cyclic CRF analogs |
| 02/20/1996 | US5492896 Pseudopeptides having an antiviral action |
| 02/20/1996 | US5492892 Endothelin antagonists |
| 02/20/1996 | US5492890 Polypeptides for promoting cell attachment |
| 02/20/1996 | US5492888 Method of using soluble human interleukin-1 receptors to suppress immune responses |
| 02/20/1996 | US5492839 Immunogenic ryanodine derivative and related uses |
| 02/20/1996 | US5492825 Mammalian inward rectifier potassium channel cDNA, IRK1, corresponding vectors, and transformed cells |
| 02/20/1996 | US5492809 Mutations rendering platelet glycoprotein Ib-α less reactive |
| 02/20/1996 | US5492808 Means for detecting familial colon cancer (FCC) |
| 02/20/1996 | US5492695 Vaccinating cats against Dirofilaria immitis with an L4 homogenate |
| 02/20/1996 | US5492694 Fusobacterium leukotoxoid vaccine |
| 02/20/1996 | US5492314 Preloaded digressive rate mount |
| 02/20/1996 | US5492135 Collagen modulators for use in photoablation excimer laser keratectomy |
| 02/20/1996 | CA2018211C Modified hvi-type hirudin and process for the manufacture thereof |
| 02/20/1996 | CA1338079C Adhesion protein micelles |
| 02/20/1996 | CA1338077C Heterodimeric transforming growth factor-beta |
| 02/20/1996 | CA1338069C Bovine herpesvirus type 1 polypeptides and vaccines |
| 02/17/1996 | CA2156132A1 Recombinant vectors derived from adenovirus for use in gene therapy |
| 02/15/1996 | WO1996004403A1 Systematic evolution of ligands by exponential enrichment: chimeric selex |
| 02/15/1996 | WO1996004397A1 Gene therapy using homologous recombination |
| 02/15/1996 | WO1996004396A1 Neural cell adhesion molecules, nucleotide sequences encoding the molecules, and methods of use thereof |
| 02/15/1996 | WO1996004393A2 Control of plant gene expression |
| 02/15/1996 | WO1996004391A1 Method for selecting high-expressing host cells |
| 02/15/1996 | WO1996004390A1 Dna sequence which acts as a chromatin insulator element to protect expressed genes from cis-acting regulatory sequences in mammalian cells |
| 02/15/1996 | WO1996004389A1 Rtk/cytokine receptor chimeras |
| 02/15/1996 | WO1996004388A1 Novel compounds |
| 02/15/1996 | WO1996004386A1 Method of using transdominant negative retroviral integrase in the treatment of retroviral infection |
| 02/15/1996 | WO1996004385A2 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use |
| 02/15/1996 | WO1996004384A1 Identification of a human cytomegalovirus gene involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004383A1 Identification of a human cytomegalovirus gene region involved in down-regulation of mhc class i heavy chain expression |
| 02/15/1996 | WO1996004382A2 Secreted viral proteins useful for vaccines and diagnostics |
| 02/15/1996 | WO1996004381A1 S. aureus fibronectin binding protein polypeptides and uses thereof |
| 02/15/1996 | WO1996004380A1 D2d3 polypeptide from staphylococcus aureus and uses thereof |
| 02/15/1996 | WO1996004379A1 Methods and compositions for the expression of a bone and prostate derived growth factor |
| 02/15/1996 | WO1996004378A2 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2 |
| 02/15/1996 | WO1996004377A1 Production of tissue factor pathway inhibitor |
| 02/15/1996 | WO1996004376A1 Hepatitis a virus receptor and methods of use |
| 02/15/1996 | WO1996004375A1 Retrovirus-induced osteoclast modulation for osteoporosis therapy |
| 02/15/1996 | WO1996004373A2 Recombinant production of biologically active peptides and proteins |
| 02/15/1996 | WO1996004372A1 Ikaros transgenic cells and animals |
| 02/15/1996 | WO1996004314A1 Mhc complexes and uses thereof |
| 02/15/1996 | WO1996004312A1 Small cell lung carcinoma peptides and binding agents |
| 02/15/1996 | WO1996004310A1 Contraceptive vaccine |
| 02/15/1996 | WO1996004309A1 Monoclonal antibodies specific for an epitope of a particular subclass or form of phosphorylated tau, hybridomas secreting them, antigen recognition of these antibodies and their applications |
| 02/15/1996 | WO1996004308A1 Cyclic hexapeptide somatostatin analogues |
| 02/15/1996 | WO1996004307A1 Aspb1 insulin analogs |
| 02/15/1996 | WO1996004306A2 Muteins of mammalian cytokines |
| 02/15/1996 | WO1996004305A1 Hybrid molecules useful in the treatment of tumors, their preparation and use in pharmaceutical compositions |
| 02/15/1996 | WO1996004304A1 Fibrin-binding peptides, dna coding therefor and uses thereof |
| 02/15/1996 | WO1996004303A1 Protein having anti-retrovirus activity and method for obtaining it |
| 02/15/1996 | WO1996004302A1 Novel tumor marker for lung cancer |
| 02/15/1996 | WO1996004301A2 Novel hepatitis c e1 and e2 truncated polypeptides and methods of obtaining the same |